Press Releases

WELLESLEY, Mass., Aug.16, 2018–Increasing acceptance of endovascular procedures and increasing diagnosis of aortic aneurysms worldwide are two factors helping to drive the endovascular treatment devices market, according to a report by BCC Research.

“Endovascular treatment (e.g., EVAR, TEVAR) has created a great buzz in the last decade due to its advantages over open surgical repair,” said BCC Research analyst and report author Dr. Ritu Thakur Dangi. “The U.S. leads the market of both segments, followed by Europe, Asia and ROW. Although Asia is growing fast, the U.S. will continue to have the largest share in the global aortic stent graft market through 2022. TAA is a relatively new and niche segment globally, but it is growing and has a strong growth potential for the future due to a strong pipeline of products from early-stage start-ups and established players.”

Growing Geriatric Population Expected to Drive Global Market

The worldwide increase in the geriatric population is helping to drive the market, the report adds, as elderly people are at a higher risk of acquiring various diseases. In the United States, average life expectancy will increase from 77.8 years in 2005 to 79.8 years in 2020, while in Europe the population 65 and older will increase at a CAGR of 1.6% between 2010 and 2030, from 121 million to 165 million. The story is similar in Japan, where the population age 65 and older will increase from 29 million in 2010 to 37 million by 2030.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.